Plain-English translation of NCT07333482 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The Flourish Study is testing whether microbiome analysis—looking at the bacteria in your baby's gut—along with personalized guidance can help babies born by cesarean section develop healthier gut bacteria and reduce early signs of allergic and immune conditions. Babies born via cesarean section often have different gut bacteria than babies born vaginally, which may increase their risk for conditions like eczema. This study wants to see if learning about and supporting your baby's gut bacteria early on can make a real difference.
Babies born by cesarean section miss exposure to beneficial bacteria they would normally receive during vaginal birth, which may increase their risk for allergies, eczema, and other immune-related problems in early life. This trial exists to find out whether analyzing your baby's gut bacteria and giving families personalized recommendations can help prevent these conditions from developing.
You likely qualify if…
You likely don't qualify if…
Over 24 months, you'll provide six small stool samples from your baby and complete surveys about your baby's health, diet, and symptoms. Depending on which group you're randomly assigned to, you'll either receive detailed microbiome reports with personalized coaching and recommendations, receive simplified reports with basic guidance, or provide the same samples and information but won't see results until the study ends. You may also have a nurse practitioner check your baby for eczema symptoms during the study.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States